India Pharma Market Examined in Cutting-edge Research Study by MP Advisors Recently Published at MarketPublishers.com
16 Mar 2015 • by Natalie Aster
LONDON – New drug pricing policy, adopted in India in 2013, had a negative influence on the domestic sales of pharmaceuticals in India. The performance of the Indian pharma market started to improve only in 2014. During 2015, the market is expected to continue following a growth trend; the market growth will likely be driven by increasing spending on healthcare in the country, supported by continued economic growth.
The US market is the biggest exports hub for the Indian generic products. However, the US market is witnessing a downward trend in channel consolidation and product approvals, which has a certain impact on overall pricing and margin for the Indian pharma industry. The US FDA has increased audits on the Indian plants of both Indian companies and multinationals. This provoked growth in a number of issuance of warning letters.
Presently, Indian pharmaceuticals producers make attempts to enter or/and expand in other markets, including Mexico, Brazil, Venezuela as well as some East European markets. This will allow the Indian companies to lessen the dependency on the US market.
The year 2015 is declared in India as ‘Year of Active Pharmaceutical Ingredients (API)’. The initiative ‘Make in India’ is anticipated to give an impetus to the introduction of favourable governmental initiatives and industry-friendly policies, which, in their turn, will likely spur the growth of the Indian bulk drug industry and turn it into a formidable force worldwide.
The comprehensive research report “India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving up the Value Chain Beyond Generics” developed by MP Advisors draws a clear picture of the current situation in the Indian pharmaceutical sector. The report includes vital information on the initiatives and policies recently introduced in the Indian pharmaceutical industry. It provides valuable data on the market size and growth dynamics, includes a snapshot of new acquisitions, partnerships and collaborations in the pharma market in India. The publication highlights the competitive landscape and scrutinizes the market opportunities and prospects in the years to come.
India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving up the Value Chain Beyond Generics
Date: February, 2015
Price: US$ 1,875.00
Other comprehensive research reports by the publisher can be found at MP Advisors page.